DUBLIN, March 4, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Barclays Global Healthcare Conference at 8:00AM ET on Wednesday, March 11, 2015 at the Loews Miami Beach Hotel in Miami, FL. Interested parties can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts.
From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products and active pharmaceutical ingredients (API), and receives royalties from Multiple Sclerosis drug Tysabri®. The Company is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo's mission is to offer uncompromised "Quality Affordable Healthcare Products®" and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as more than 40 other key markets worldwide, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).
Logo - http://photos.prnewswire.com/prnh/20120301/DE62255LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/perrigo-company-to-present-at-the-2015-barclays-global-healthcare-conference-300045270.html
For further information: Arthur J. Shannon, Vice President, Investor Relations and Global Communications, (269) 686-1709, E-mail: email@example.com, Bradley Joseph, Director, Investor Relations and Global Communications, (269) 686-3373, E-mail: firstname.lastname@example.org